nodes	percent_of_prediction	percent_of_DWPC	metapath
Atomoxetine—Propranolol—migraine	0.277	1	CrCtD
Atomoxetine—HTR1D—migraine	0.0865	0.359	CbGaD
Atomoxetine—HTR1B—migraine	0.0513	0.213	CbGaD
Atomoxetine—HTR2C—migraine	0.0418	0.174	CbGaD
Atomoxetine—SLC6A4—migraine	0.0347	0.144	CbGaD
Atomoxetine—HTR2A—migraine	0.0266	0.111	CbGaD
Atomoxetine—Duloxetine—Propranolol—migraine	0.0243	0.129	CrCrCtD
Atomoxetine—Indecainide—Amitriptyline—migraine	0.0219	0.117	CrCrCtD
Atomoxetine—HTR1B—Propranolol—migraine	0.019	0.108	CbGbCtD
Atomoxetine—HTR6—Amitriptyline—migraine	0.0188	0.107	CbGbCtD
Atomoxetine—HTR1D—Amitriptyline—migraine	0.0171	0.0975	CbGbCtD
Atomoxetine—Demexiptiline—Propranolol—migraine	0.0171	0.0908	CrCrCtD
Atomoxetine—Indecainide—Propranolol—migraine	0.0171	0.0908	CrCrCtD
Atomoxetine—HTR1B—Amitriptyline—migraine	0.0164	0.0934	CbGbCtD
Atomoxetine—Nortriptyline—Amitriptyline—migraine	0.0153	0.0812	CrCrCtD
Atomoxetine—SLC6A4—Amitriptyline—migraine	0.013	0.0742	CbGbCtD
Atomoxetine—Propafenone—Propranolol—migraine	0.0128	0.0682	CrCrCtD
Atomoxetine—Phenindione—Amitriptyline—migraine	0.0126	0.067	CrCrCtD
Atomoxetine—Doxylamine—Amitriptyline—migraine	0.0119	0.0634	CrCrCtD
Atomoxetine—Desipramine—Amitriptyline—migraine	0.0119	0.0634	CrCrCtD
Atomoxetine—HTR2C—Amitriptyline—migraine	0.0109	0.0621	CbGbCtD
Atomoxetine—SLC6A2—Amitriptyline—migraine	0.0109	0.0621	CbGbCtD
Atomoxetine—SLC6A4—Verapamil—migraine	0.0103	0.0589	CbGbCtD
Atomoxetine—Bromodiphenhydramine—Amitriptyline—migraine	0.0101	0.0536	CrCrCtD
Atomoxetine—Pheniramine—Amitriptyline—migraine	0.00987	0.0525	CrCrCtD
Atomoxetine—HTR2A—Amitriptyline—migraine	0.00983	0.056	CbGbCtD
Atomoxetine—Clofedanol—Amitriptyline—migraine	0.00819	0.0435	CrCrCtD
Atomoxetine—Orphenadrine—Amitriptyline—migraine	0.00792	0.0421	CrCrCtD
Atomoxetine—Diphenhydramine—Amitriptyline—migraine	0.00704	0.0374	CrCrCtD
Atomoxetine—CYP2C19—Timolol—migraine	0.00558	0.0318	CbGbCtD
Atomoxetine—CYP2C19—Propranolol—migraine	0.00497	0.0283	CbGbCtD
Atomoxetine—CYP2C19—Amitriptyline—migraine	0.0043	0.0245	CbGbCtD
Atomoxetine—CYP2D6—Timolol—migraine	0.00424	0.0241	CbGbCtD
Atomoxetine—CYP2C19—Valproic Acid—migraine	0.00392	0.0223	CbGbCtD
Atomoxetine—CYP2D6—Propranolol—migraine	0.00378	0.0215	CbGbCtD
Atomoxetine—HTR1B—trigeminal nucleus—migraine	0.00354	0.117	CbGeAlD
Atomoxetine—CYP2C19—Topiramate—migraine	0.00354	0.0201	CbGbCtD
Atomoxetine—HTR1D—trigeminal nucleus—migraine	0.00343	0.113	CbGeAlD
Atomoxetine—CYP2C19—Verapamil—migraine	0.00341	0.0194	CbGbCtD
Atomoxetine—CYP2D6—Amitriptyline—migraine	0.00327	0.0186	CbGbCtD
Atomoxetine—CYP2D6—Verapamil—migraine	0.0026	0.0148	CbGbCtD
Atomoxetine—CYP3A4—Propranolol—migraine	0.0024	0.0137	CbGbCtD
Atomoxetine—HTR1D—meninx—migraine	0.00228	0.0749	CbGeAlD
Atomoxetine—HTR1B—dura mater—migraine	0.00216	0.0712	CbGeAlD
Atomoxetine—HTR1D—dura mater—migraine	0.00209	0.0689	CbGeAlD
Atomoxetine—CYP3A4—Amitriptyline—migraine	0.00208	0.0118	CbGbCtD
Atomoxetine—CYP3A4—Valproic Acid—migraine	0.0019	0.0108	CbGbCtD
Atomoxetine—CYP3A4—Topiramate—migraine	0.00171	0.00974	CbGbCtD
Atomoxetine—HTR2A—trigeminal nucleus—migraine	0.0017	0.0561	CbGeAlD
Atomoxetine—CYP3A4—Verapamil—migraine	0.00165	0.00939	CbGbCtD
Atomoxetine—HTR1B—trigeminal nerve—migraine	0.00093	0.0306	CbGeAlD
Atomoxetine—SLC6A2—locus ceruleus—migraine	0.000909	0.0299	CbGeAlD
Atomoxetine—HTR1D—trigeminal nerve—migraine	0.000901	0.0296	CbGeAlD
Atomoxetine—NPY1R—nerve—migraine	0.000801	0.0264	CbGeAlD
Atomoxetine—SLC6A2—sympathetic nervous system—migraine	0.000719	0.0237	CbGeAlD
Atomoxetine—HTR1B—cranial nerve—migraine	0.000663	0.0218	CbGeAlD
Atomoxetine—HTR1D—cranial nerve—migraine	0.000642	0.0211	CbGeAlD
Atomoxetine—HTR2A—locus ceruleus—migraine	0.000547	0.018	CbGeAlD
Atomoxetine—SLC6A2—autonomic nervous system—migraine	0.000483	0.0159	CbGeAlD
Atomoxetine—HTR2A—trigeminal nerve—migraine	0.000447	0.0147	CbGeAlD
Atomoxetine—HTR2A—sympathetic nervous system—migraine	0.000432	0.0142	CbGeAlD
Atomoxetine—SLC6A3—nerve—migraine	0.000337	0.0111	CbGeAlD
Atomoxetine—HTR2A—cranial nerve—migraine	0.000319	0.0105	CbGeAlD
Atomoxetine—HTR2A—pons—migraine	0.000315	0.0104	CbGeAlD
Atomoxetine—HTR2A—autonomic nervous system—migraine	0.00029	0.00956	CbGeAlD
Atomoxetine—SLC6A2—nerve—migraine	0.000272	0.00895	CbGeAlD
Atomoxetine—HTR1B—blood vessel—migraine	0.000267	0.00878	CbGeAlD
Atomoxetine—HTR1D—blood vessel—migraine	0.000258	0.0085	CbGeAlD
Atomoxetine—HTR2A—pineal body—migraine	0.000225	0.0074	CbGeAlD
Atomoxetine—HTR2A—peripheral nervous system—migraine	0.00021	0.0069	CbGeAlD
Atomoxetine—NPY1R—head—migraine	0.00019	0.00625	CbGeAlD
Atomoxetine—NPY1R—nervous system—migraine	0.00018	0.00593	CbGeAlD
Atomoxetine—NPY1R—central nervous system—migraine	0.000173	0.00571	CbGeAlD
Atomoxetine—HTR1B—trigeminal ganglion—migraine	0.000165	0.00542	CbGeAlD
Atomoxetine—HTR2A—nerve—migraine	0.000163	0.00538	CbGeAlD
Atomoxetine—HTR1D—trigeminal ganglion—migraine	0.00016	0.00525	CbGeAlD
Atomoxetine—HTR1B—brainstem—migraine	0.000146	0.0048	CbGeAlD
Atomoxetine—SLC6A3—brainstem—migraine	0.000145	0.00476	CbGeAlD
Atomoxetine—HTR1D—brainstem—migraine	0.000141	0.00465	CbGeAlD
Atomoxetine—HTR2C—brainstem—migraine	0.00014	0.0046	CbGeAlD
Atomoxetine—NPY1R—brain—migraine	0.000138	0.00453	CbGeAlD
Atomoxetine—HTR6—head—migraine	0.000134	0.0044	CbGeAlD
Atomoxetine—SLC6A4—brainstem—migraine	0.000133	0.00436	CbGeAlD
Atomoxetine—HTR2A—blood vessel—migraine	0.000128	0.00422	CbGeAlD
Atomoxetine—HTR6—nervous system—migraine	0.000127	0.00417	CbGeAlD
Atomoxetine—HTR6—central nervous system—migraine	0.000122	0.00402	CbGeAlD
Atomoxetine—HTR1B—cardiovascular system—migraine	0.000119	0.00392	CbGeAlD
Atomoxetine—Reboxetine—HTR2C—migraine	0.000117	0.0757	CrCbGaD
Atomoxetine—SLC6A2—brainstem—migraine	0.000117	0.00384	CbGeAlD
Atomoxetine—HTR1D—cardiovascular system—migraine	0.000115	0.00379	CbGeAlD
Atomoxetine—HTR6—brain—migraine	9.69e-05	0.00319	CbGeAlD
Atomoxetine—Reboxetine—SLC6A4—migraine	9.68e-05	0.0627	CrCbGaD
Atomoxetine—HTR2A—neck—migraine	9.18e-05	0.00302	CbGeAlD
Atomoxetine—Orphenadrine—SCN1A—migraine	8.99e-05	0.0582	CrCbGaD
Atomoxetine—Duloxetine—HTR2C—migraine	8.98e-05	0.0582	CrCbGaD
Atomoxetine—Protriptyline—SLC6A4—migraine	8.89e-05	0.0576	CrCbGaD
Atomoxetine—Maprotiline—HTR7—migraine	8.66e-05	0.0561	CrCbGaD
Atomoxetine—HTR1B—head—migraine	8.06e-05	0.00265	CbGeAlD
Atomoxetine—SLC6A3—head—migraine	7.99e-05	0.00263	CbGeAlD
Atomoxetine—HTR1D—head—migraine	7.8e-05	0.00257	CbGeAlD
Atomoxetine—HTR2C—head—migraine	7.73e-05	0.00254	CbGeAlD
Atomoxetine—Methadone—HTR3A—migraine	7.67e-05	0.0497	CrCbGaD
Atomoxetine—HTR1B—nervous system—migraine	7.64e-05	0.00251	CbGeAlD
Atomoxetine—SLC6A3—nervous system—migraine	7.58e-05	0.00249	CbGeAlD
Atomoxetine—Duloxetine—SLC6A4—migraine	7.44e-05	0.0482	CrCbGaD
Atomoxetine—HTR1D—nervous system—migraine	7.4e-05	0.00243	CbGeAlD
Atomoxetine—HTR1B—central nervous system—migraine	7.36e-05	0.00242	CbGeAlD
Atomoxetine—HTR2C—nervous system—migraine	7.32e-05	0.00241	CbGeAlD
Atomoxetine—SLC6A4—head—migraine	7.32e-05	0.00241	CbGeAlD
Atomoxetine—Fluoxetine—HTR2C—migraine	7.32e-05	0.0474	CrCbGaD
Atomoxetine—SLC6A3—central nervous system—migraine	7.3e-05	0.0024	CbGeAlD
Atomoxetine—SLC6A3—cerebellum—migraine	7.13e-05	0.00235	CbGeAlD
Atomoxetine—HTR1D—central nervous system—migraine	7.12e-05	0.00234	CbGeAlD
Atomoxetine—HTR2C—central nervous system—migraine	7.05e-05	0.00232	CbGeAlD
Atomoxetine—HTR2A—brainstem—migraine	7.01e-05	0.00231	CbGeAlD
Atomoxetine—SLC6A4—nervous system—migraine	6.94e-05	0.00229	CbGeAlD
Atomoxetine—Maprotiline—HTR2C—migraine	6.84e-05	0.0443	CrCbGaD
Atomoxetine—SLC6A4—central nervous system—migraine	6.69e-05	0.0022	CbGeAlD
Atomoxetine—Pseudoephedrine—TNF—migraine	6.55e-05	0.0424	CrCbGaD
Atomoxetine—SLC6A2—head—migraine	6.45e-05	0.00212	CbGeAlD
Atomoxetine—CYP2D6—brainstem—migraine	6.39e-05	0.0021	CbGeAlD
Atomoxetine—SLC6A2—nervous system—migraine	6.11e-05	0.00201	CbGeAlD
Atomoxetine—Fluoxetine—SLC6A4—migraine	6.07e-05	0.0393	CrCbGaD
Atomoxetine—SLC6A2—central nervous system—migraine	5.89e-05	0.00194	CbGeAlD
Atomoxetine—HTR1B—brain—migraine	5.84e-05	0.00192	CbGeAlD
Atomoxetine—SLC6A3—brain—migraine	5.79e-05	0.00191	CbGeAlD
Atomoxetine—Rash—Amitriptyline—migraine	5.74e-05	0.00116	CcSEcCtD
Atomoxetine—Dermatitis—Amitriptyline—migraine	5.74e-05	0.00116	CcSEcCtD
Atomoxetine—Back pain—Valproic Acid—migraine	5.73e-05	0.00116	CcSEcCtD
Atomoxetine—HTR2A—cardiovascular system—migraine	5.72e-05	0.00188	CbGeAlD
Atomoxetine—Duloxetine—HTR2A—migraine	5.72e-05	0.037	CrCbGaD
Atomoxetine—Headache—Amitriptyline—migraine	5.71e-05	0.00115	CcSEcCtD
Atomoxetine—Muscle spasms—Valproic Acid—migraine	5.7e-05	0.00115	CcSEcCtD
Atomoxetine—Abdominal discomfort—Topiramate—migraine	5.69e-05	0.00115	CcSEcCtD
Atomoxetine—HTR1D—brain—migraine	5.65e-05	0.00186	CbGeAlD
Atomoxetine—Cardiac disorder—Timolol—migraine	5.63e-05	0.00114	CcSEcCtD
Atomoxetine—Feeling abnormal—Verapamil—migraine	5.62e-05	0.00114	CcSEcCtD
Atomoxetine—Hypoaesthesia—Gabapentin—migraine	5.62e-05	0.00114	CcSEcCtD
Atomoxetine—Hallucination—Gabapentin—migraine	5.62e-05	0.00114	CcSEcCtD
Atomoxetine—HTR2C—brain—migraine	5.6e-05	0.00184	CbGeAlD
Atomoxetine—Vision blurred—Valproic Acid—migraine	5.59e-05	0.00113	CcSEcCtD
Atomoxetine—Urinary tract disorder—Gabapentin—migraine	5.57e-05	0.00113	CcSEcCtD
Atomoxetine—Tremor—Valproic Acid—migraine	5.55e-05	0.00112	CcSEcCtD
Atomoxetine—Dysuria—Topiramate—migraine	5.55e-05	0.00112	CcSEcCtD
Atomoxetine—Urethral disorder—Gabapentin—migraine	5.53e-05	0.00112	CcSEcCtD
Atomoxetine—Upper respiratory tract infection—Topiramate—migraine	5.51e-05	0.00112	CcSEcCtD
Atomoxetine—Angiopathy—Timolol—migraine	5.5e-05	0.00111	CcSEcCtD
Atomoxetine—Propranolol—HTR1B—migraine	5.48e-05	0.0355	CrCbGaD
Atomoxetine—Pollakiuria—Topiramate—migraine	5.48e-05	0.00111	CcSEcCtD
Atomoxetine—Erectile dysfunction—Topiramate—migraine	5.46e-05	0.00111	CcSEcCtD
Atomoxetine—Mediastinal disorder—Timolol—migraine	5.46e-05	0.00111	CcSEcCtD
Atomoxetine—Agitation—Valproic Acid—migraine	5.45e-05	0.0011	CcSEcCtD
Atomoxetine—Urticaria—Verapamil—migraine	5.42e-05	0.0011	CcSEcCtD
Atomoxetine—Nausea—Amitriptyline—migraine	5.41e-05	0.00109	CcSEcCtD
Atomoxetine—Weight decreased—Topiramate—migraine	5.37e-05	0.00109	CcSEcCtD
Atomoxetine—Vertigo—Valproic Acid—migraine	5.32e-05	0.00108	CcSEcCtD
Atomoxetine—Asthenia—Propranolol—migraine	5.32e-05	0.00108	CcSEcCtD
Atomoxetine—Mental disorder—Timolol—migraine	5.31e-05	0.00107	CcSEcCtD
Atomoxetine—SLC6A4—brain—migraine	5.31e-05	0.00175	CbGeAlD
Atomoxetine—Infestation—Topiramate—migraine	5.29e-05	0.00107	CcSEcCtD
Atomoxetine—Infestation NOS—Topiramate—migraine	5.29e-05	0.00107	CcSEcCtD
Atomoxetine—Malnutrition—Timolol—migraine	5.28e-05	0.00107	CcSEcCtD
Atomoxetine—Depression—Topiramate—migraine	5.27e-05	0.00107	CcSEcCtD
Atomoxetine—Pseudoephedrine—SLC6A4—migraine	5.27e-05	0.0341	CrCbGaD
Atomoxetine—Cardiac disorder—Gabapentin—migraine	5.24e-05	0.00106	CcSEcCtD
Atomoxetine—Palpitations—Valproic Acid—migraine	5.24e-05	0.00106	CcSEcCtD
Atomoxetine—Tension—Timolol—migraine	5.18e-05	0.00105	CcSEcCtD
Atomoxetine—Cough—Valproic Acid—migraine	5.17e-05	0.00105	CcSEcCtD
Atomoxetine—Dysgeusia—Timolol—migraine	5.17e-05	0.00105	CcSEcCtD
Atomoxetine—Conjunctivitis—Topiramate—migraine	5.14e-05	0.00104	CcSEcCtD
Atomoxetine—Nervousness—Timolol—migraine	5.12e-05	0.00104	CcSEcCtD
Atomoxetine—Mediastinal disorder—Gabapentin—migraine	5.09e-05	0.00103	CcSEcCtD
Atomoxetine—Diarrhoea—Propranolol—migraine	5.07e-05	0.00103	CcSEcCtD
Atomoxetine—Chills—Gabapentin—migraine	5.06e-05	0.00102	CcSEcCtD
Atomoxetine—Arthralgia—Valproic Acid—migraine	5.05e-05	0.00102	CcSEcCtD
Atomoxetine—Chest pain—Valproic Acid—migraine	5.05e-05	0.00102	CcSEcCtD
Atomoxetine—Myalgia—Valproic Acid—migraine	5.05e-05	0.00102	CcSEcCtD
Atomoxetine—Anxiety—Valproic Acid—migraine	5.03e-05	0.00102	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	5.01e-05	0.00101	CcSEcCtD
Atomoxetine—Vision blurred—Timolol—migraine	4.97e-05	0.00101	CcSEcCtD
Atomoxetine—Sinusitis—Topiramate—migraine	4.96e-05	0.001	CcSEcCtD
Atomoxetine—Mental disorder—Gabapentin—migraine	4.94e-05	0.001	CcSEcCtD
Atomoxetine—Dry mouth—Valproic Acid—migraine	4.93e-05	0.000998	CcSEcCtD
Atomoxetine—Malnutrition—Gabapentin—migraine	4.91e-05	0.000994	CcSEcCtD
Atomoxetine—Dizziness—Propranolol—migraine	4.9e-05	0.000992	CcSEcCtD
Atomoxetine—Asthenia—Verapamil—migraine	4.89e-05	0.00099	CcSEcCtD
Atomoxetine—Flatulence—Gabapentin—migraine	4.84e-05	0.00098	CcSEcCtD
Atomoxetine—Pruritus—Verapamil—migraine	4.83e-05	0.000977	CcSEcCtD
Atomoxetine—Tension—Gabapentin—migraine	4.82e-05	0.000976	CcSEcCtD
Atomoxetine—Dysgeusia—Gabapentin—migraine	4.81e-05	0.000974	CcSEcCtD
Atomoxetine—Infection—Valproic Acid—migraine	4.81e-05	0.000972	CcSEcCtD
Atomoxetine—Nervousness—Gabapentin—migraine	4.77e-05	0.000966	CcSEcCtD
Atomoxetine—Back pain—Gabapentin—migraine	4.75e-05	0.000962	CcSEcCtD
Atomoxetine—Nervous system disorder—Valproic Acid—migraine	4.74e-05	0.00096	CcSEcCtD
Atomoxetine—Vertigo—Timolol—migraine	4.74e-05	0.000959	CcSEcCtD
Atomoxetine—Syncope—Timolol—migraine	4.73e-05	0.000957	CcSEcCtD
Atomoxetine—Hypoaesthesia—Topiramate—migraine	4.72e-05	0.000956	CcSEcCtD
Atomoxetine—Hallucination—Topiramate—migraine	4.72e-05	0.000956	CcSEcCtD
Atomoxetine—Muscle spasms—Gabapentin—migraine	4.72e-05	0.000956	CcSEcCtD
Atomoxetine—Tachycardia—Valproic Acid—migraine	4.72e-05	0.000955	CcSEcCtD
Atomoxetine—Vomiting—Propranolol—migraine	4.72e-05	0.000954	CcSEcCtD
Atomoxetine—Skin disorder—Valproic Acid—migraine	4.7e-05	0.000951	CcSEcCtD
Atomoxetine—Urinary tract disorder—Topiramate—migraine	4.69e-05	0.000949	CcSEcCtD
Atomoxetine—Hyperhidrosis—Valproic Acid—migraine	4.68e-05	0.000946	CcSEcCtD
Atomoxetine—Rash—Propranolol—migraine	4.68e-05	0.000946	CcSEcCtD
Atomoxetine—SLC6A2—brain—migraine	4.67e-05	0.00154	CbGeAlD
Atomoxetine—Dermatitis—Propranolol—migraine	4.67e-05	0.000945	CcSEcCtD
Atomoxetine—Diarrhoea—Verapamil—migraine	4.67e-05	0.000944	CcSEcCtD
Atomoxetine—Palpitations—Timolol—migraine	4.66e-05	0.000943	CcSEcCtD
Atomoxetine—Fluoxetine—HTR2A—migraine	4.66e-05	0.0302	CrCbGaD
Atomoxetine—Urethral disorder—Topiramate—migraine	4.65e-05	0.000942	CcSEcCtD
Atomoxetine—Loss of consciousness—Timolol—migraine	4.64e-05	0.000938	CcSEcCtD
Atomoxetine—Vision blurred—Gabapentin—migraine	4.63e-05	0.000937	CcSEcCtD
Atomoxetine—Anorexia—Valproic Acid—migraine	4.61e-05	0.000933	CcSEcCtD
Atomoxetine—Cough—Timolol—migraine	4.6e-05	0.000932	CcSEcCtD
Atomoxetine—Tremor—Gabapentin—migraine	4.6e-05	0.000931	CcSEcCtD
Atomoxetine—Agitation—Gabapentin—migraine	4.52e-05	0.000914	CcSEcCtD
Atomoxetine—Dizziness—Verapamil—migraine	4.51e-05	0.000913	CcSEcCtD
Atomoxetine—Arthralgia—Timolol—migraine	4.49e-05	0.000909	CcSEcCtD
Atomoxetine—Chest pain—Timolol—migraine	4.49e-05	0.000909	CcSEcCtD
Atomoxetine—Myalgia—Timolol—migraine	4.49e-05	0.000909	CcSEcCtD
Atomoxetine—Anxiety—Timolol—migraine	4.48e-05	0.000906	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	4.46e-05	0.000903	CcSEcCtD
Atomoxetine—Vertigo—Gabapentin—migraine	4.41e-05	0.000893	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Valproic Acid—migraine	4.41e-05	0.000892	CcSEcCtD
Atomoxetine—Flushing—Topiramate—migraine	4.41e-05	0.000892	CcSEcCtD
Atomoxetine—Cardiac disorder—Topiramate—migraine	4.41e-05	0.000892	CcSEcCtD
Atomoxetine—Syncope—Gabapentin—migraine	4.41e-05	0.000891	CcSEcCtD
Atomoxetine—Nausea—Propranolol—migraine	4.41e-05	0.000891	CcSEcCtD
Atomoxetine—Dry mouth—Timolol—migraine	4.39e-05	0.000889	CcSEcCtD
Atomoxetine—Insomnia—Valproic Acid—migraine	4.37e-05	0.000885	CcSEcCtD
Atomoxetine—Maprotiline—HTR2A—migraine	4.36e-05	0.0282	CrCbGaD
Atomoxetine—Paraesthesia—Valproic Acid—migraine	4.34e-05	0.000879	CcSEcCtD
Atomoxetine—Palpitations—Gabapentin—migraine	4.34e-05	0.000879	CcSEcCtD
Atomoxetine—Vomiting—Verapamil—migraine	4.34e-05	0.000878	CcSEcCtD
Atomoxetine—Propranolol—HTR1A—migraine	4.34e-05	0.0281	CrCbGaD
Atomoxetine—Loss of consciousness—Gabapentin—migraine	4.32e-05	0.000874	CcSEcCtD
Atomoxetine—Angiopathy—Topiramate—migraine	4.31e-05	0.000872	CcSEcCtD
Atomoxetine—Rash—Verapamil—migraine	4.3e-05	0.00087	CcSEcCtD
Atomoxetine—Somnolence—Valproic Acid—migraine	4.3e-05	0.00087	CcSEcCtD
Atomoxetine—Dermatitis—Verapamil—migraine	4.3e-05	0.00087	CcSEcCtD
Atomoxetine—Cough—Gabapentin—migraine	4.29e-05	0.000867	CcSEcCtD
Atomoxetine—Mediastinal disorder—Topiramate—migraine	4.28e-05	0.000866	CcSEcCtD
Atomoxetine—Infection—Timolol—migraine	4.28e-05	0.000866	CcSEcCtD
Atomoxetine—Headache—Verapamil—migraine	4.27e-05	0.000865	CcSEcCtD
Atomoxetine—Chills—Topiramate—migraine	4.26e-05	0.000862	CcSEcCtD
Atomoxetine—Dyspepsia—Valproic Acid—migraine	4.26e-05	0.000861	CcSEcCtD
Atomoxetine—Convulsion—Gabapentin—migraine	4.26e-05	0.000861	CcSEcCtD
Atomoxetine—Shock—Timolol—migraine	4.24e-05	0.000857	CcSEcCtD
Atomoxetine—Nervous system disorder—Timolol—migraine	4.22e-05	0.000854	CcSEcCtD
Atomoxetine—Decreased appetite—Valproic Acid—migraine	4.2e-05	0.000851	CcSEcCtD
Atomoxetine—Arthralgia—Gabapentin—migraine	4.18e-05	0.000846	CcSEcCtD
Atomoxetine—Myalgia—Gabapentin—migraine	4.18e-05	0.000846	CcSEcCtD
Atomoxetine—Chest pain—Gabapentin—migraine	4.18e-05	0.000846	CcSEcCtD
Atomoxetine—Skin disorder—Timolol—migraine	4.18e-05	0.000846	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Valproic Acid—migraine	4.18e-05	0.000845	CcSEcCtD
Atomoxetine—Fatigue—Valproic Acid—migraine	4.17e-05	0.000844	CcSEcCtD
Atomoxetine—Anxiety—Gabapentin—migraine	4.17e-05	0.000843	CcSEcCtD
Atomoxetine—Hyperhidrosis—Timolol—migraine	4.16e-05	0.000842	CcSEcCtD
Atomoxetine—Mental disorder—Topiramate—migraine	4.16e-05	0.000842	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	4.15e-05	0.000841	CcSEcCtD
Atomoxetine—Pain—Valproic Acid—migraine	4.14e-05	0.000837	CcSEcCtD
Atomoxetine—Constipation—Valproic Acid—migraine	4.14e-05	0.000837	CcSEcCtD
Atomoxetine—Malnutrition—Topiramate—migraine	4.13e-05	0.000836	CcSEcCtD
Atomoxetine—Nortriptyline—HTR2C—migraine	4.11e-05	0.0266	CrCbGaD
Atomoxetine—Anorexia—Timolol—migraine	4.1e-05	0.00083	CcSEcCtD
Atomoxetine—Dry mouth—Gabapentin—migraine	4.09e-05	0.000828	CcSEcCtD
Atomoxetine—Flatulence—Topiramate—migraine	4.07e-05	0.000824	CcSEcCtD
Atomoxetine—Tension—Topiramate—migraine	4.06e-05	0.000821	CcSEcCtD
Atomoxetine—Nausea—Verapamil—migraine	4.05e-05	0.00082	CcSEcCtD
Atomoxetine—Dysgeusia—Topiramate—migraine	4.05e-05	0.000819	CcSEcCtD
Atomoxetine—Nervousness—Topiramate—migraine	4.01e-05	0.000812	CcSEcCtD
Atomoxetine—Back pain—Topiramate—migraine	4e-05	0.000809	CcSEcCtD
Atomoxetine—Nortriptyline—HTR1A—migraine	3.99e-05	0.0258	CrCbGaD
Atomoxetine—Feeling abnormal—Valproic Acid—migraine	3.99e-05	0.000806	CcSEcCtD
Atomoxetine—Infection—Gabapentin—migraine	3.98e-05	0.000806	CcSEcCtD
Atomoxetine—Muscle spasms—Topiramate—migraine	3.97e-05	0.000804	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Valproic Acid—migraine	3.96e-05	0.0008	CcSEcCtD
Atomoxetine—Shock—Gabapentin—migraine	3.95e-05	0.000798	CcSEcCtD
Atomoxetine—Nervous system disorder—Gabapentin—migraine	3.93e-05	0.000796	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Timolol—migraine	3.92e-05	0.000794	CcSEcCtD
Atomoxetine—Tachycardia—Gabapentin—migraine	3.91e-05	0.000792	CcSEcCtD
Atomoxetine—Vision blurred—Topiramate—migraine	3.9e-05	0.000788	CcSEcCtD
Atomoxetine—Skin disorder—Gabapentin—migraine	3.89e-05	0.000788	CcSEcCtD
Atomoxetine—Insomnia—Timolol—migraine	3.89e-05	0.000788	CcSEcCtD
Atomoxetine—Hyperhidrosis—Gabapentin—migraine	3.88e-05	0.000784	CcSEcCtD
Atomoxetine—HTR2A—head—migraine	3.88e-05	0.00128	CbGeAlD
Atomoxetine—Tremor—Topiramate—migraine	3.87e-05	0.000784	CcSEcCtD
Atomoxetine—Paraesthesia—Timolol—migraine	3.87e-05	0.000782	CcSEcCtD
Atomoxetine—Urticaria—Valproic Acid—migraine	3.84e-05	0.000777	CcSEcCtD
Atomoxetine—Somnolence—Timolol—migraine	3.83e-05	0.000775	CcSEcCtD
Atomoxetine—Abdominal pain—Valproic Acid—migraine	3.82e-05	0.000774	CcSEcCtD
Atomoxetine—Body temperature increased—Valproic Acid—migraine	3.82e-05	0.000774	CcSEcCtD
Atomoxetine—Anorexia—Gabapentin—migraine	3.82e-05	0.000773	CcSEcCtD
Atomoxetine—Agitation—Topiramate—migraine	3.8e-05	0.000769	CcSEcCtD
Atomoxetine—Dyspepsia—Timolol—migraine	3.79e-05	0.000767	CcSEcCtD
Atomoxetine—Decreased appetite—Timolol—migraine	3.74e-05	0.000757	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Timolol—migraine	3.72e-05	0.000752	CcSEcCtD
Atomoxetine—Vertigo—Topiramate—migraine	3.71e-05	0.000751	CcSEcCtD
Atomoxetine—Fatigue—Timolol—migraine	3.71e-05	0.000751	CcSEcCtD
Atomoxetine—Syncope—Topiramate—migraine	3.71e-05	0.00075	CcSEcCtD
Atomoxetine—Pain—Timolol—migraine	3.68e-05	0.000745	CcSEcCtD
Atomoxetine—HTR2A—nervous system—migraine	3.67e-05	0.00121	CbGeAlD
Atomoxetine—Musculoskeletal discomfort—Gabapentin—migraine	3.65e-05	0.000739	CcSEcCtD
Atomoxetine—Palpitations—Topiramate—migraine	3.65e-05	0.000739	CcSEcCtD
Atomoxetine—Loss of consciousness—Topiramate—migraine	3.63e-05	0.000735	CcSEcCtD
Atomoxetine—Insomnia—Gabapentin—migraine	3.63e-05	0.000734	CcSEcCtD
Atomoxetine—Cough—Topiramate—migraine	3.61e-05	0.00073	CcSEcCtD
Atomoxetine—Paraesthesia—Gabapentin—migraine	3.6e-05	0.000729	CcSEcCtD
Atomoxetine—Convulsion—Topiramate—migraine	3.58e-05	0.000725	CcSEcCtD
Atomoxetine—Somnolence—Gabapentin—migraine	3.56e-05	0.000721	CcSEcCtD
Atomoxetine—Feeling abnormal—Timolol—migraine	3.55e-05	0.000718	CcSEcCtD
Atomoxetine—HTR2A—central nervous system—migraine	3.54e-05	0.00116	CbGeAlD
Atomoxetine—CYP2D6—head—migraine	3.53e-05	0.00116	CbGeAlD
Atomoxetine—Dyspepsia—Gabapentin—migraine	3.53e-05	0.000714	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Timolol—migraine	3.52e-05	0.000712	CcSEcCtD
Atomoxetine—Chest pain—Topiramate—migraine	3.52e-05	0.000712	CcSEcCtD
Atomoxetine—Myalgia—Topiramate—migraine	3.52e-05	0.000712	CcSEcCtD
Atomoxetine—Arthralgia—Topiramate—migraine	3.52e-05	0.000712	CcSEcCtD
Atomoxetine—Anxiety—Topiramate—migraine	3.51e-05	0.00071	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	3.49e-05	0.000707	CcSEcCtD
Atomoxetine—Decreased appetite—Gabapentin—migraine	3.49e-05	0.000705	CcSEcCtD
Atomoxetine—Asthenia—Valproic Acid—migraine	3.47e-05	0.000702	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Gabapentin—migraine	3.46e-05	0.0007	CcSEcCtD
Atomoxetine—HTR2A—cerebellum—migraine	3.46e-05	0.00114	CbGeAlD
Atomoxetine—Fatigue—Gabapentin—migraine	3.46e-05	0.000699	CcSEcCtD
Atomoxetine—Dry mouth—Topiramate—migraine	3.44e-05	0.000696	CcSEcCtD
Atomoxetine—Constipation—Gabapentin—migraine	3.43e-05	0.000694	CcSEcCtD
Atomoxetine—Pain—Gabapentin—migraine	3.43e-05	0.000694	CcSEcCtD
Atomoxetine—Pruritus—Valproic Acid—migraine	3.42e-05	0.000692	CcSEcCtD
Atomoxetine—Urticaria—Timolol—migraine	3.42e-05	0.000692	CcSEcCtD
Atomoxetine—Nortriptyline—SLC6A4—migraine	3.4e-05	0.0221	CrCbGaD
Atomoxetine—Abdominal pain—Timolol—migraine	3.4e-05	0.000689	CcSEcCtD
Atomoxetine—Body temperature increased—Timolol—migraine	3.4e-05	0.000689	CcSEcCtD
Atomoxetine—CYP3A4—nervous system—migraine	3.4e-05	0.00112	CbGeAlD
Atomoxetine—Desipramine—HTR2C—migraine	3.38e-05	0.0219	CrCbGaD
Atomoxetine—Infection—Topiramate—migraine	3.35e-05	0.000678	CcSEcCtD
Atomoxetine—CYP2D6—nervous system—migraine	3.35e-05	0.0011	CbGeAlD
Atomoxetine—Shock—Topiramate—migraine	3.32e-05	0.000672	CcSEcCtD
Atomoxetine—Diarrhoea—Valproic Acid—migraine	3.31e-05	0.00067	CcSEcCtD
Atomoxetine—Nervous system disorder—Topiramate—migraine	3.31e-05	0.000669	CcSEcCtD
Atomoxetine—Feeling abnormal—Gabapentin—migraine	3.3e-05	0.000669	CcSEcCtD
Atomoxetine—Tachycardia—Topiramate—migraine	3.29e-05	0.000666	CcSEcCtD
Atomoxetine—Desipramine—HTR1A—migraine	3.28e-05	0.0213	CrCbGaD
Atomoxetine—Gastrointestinal pain—Gabapentin—migraine	3.28e-05	0.000663	CcSEcCtD
Atomoxetine—Skin disorder—Topiramate—migraine	3.28e-05	0.000663	CcSEcCtD
Atomoxetine—CYP3A4—central nervous system—migraine	3.27e-05	0.00108	CbGeAlD
Atomoxetine—Hyperhidrosis—Topiramate—migraine	3.26e-05	0.00066	CcSEcCtD
Atomoxetine—CYP2D6—central nervous system—migraine	3.22e-05	0.00106	CbGeAlD
Atomoxetine—Anorexia—Topiramate—migraine	3.22e-05	0.000651	CcSEcCtD
Atomoxetine—Dizziness—Valproic Acid—migraine	3.2e-05	0.000647	CcSEcCtD
Atomoxetine—Urticaria—Gabapentin—migraine	3.19e-05	0.000645	CcSEcCtD
Atomoxetine—Body temperature increased—Gabapentin—migraine	3.17e-05	0.000641	CcSEcCtD
Atomoxetine—Abdominal pain—Gabapentin—migraine	3.17e-05	0.000641	CcSEcCtD
Atomoxetine—CYP2D6—cerebellum—migraine	3.15e-05	0.00104	CbGeAlD
Atomoxetine—Asthenia—Timolol—migraine	3.09e-05	0.000625	CcSEcCtD
Atomoxetine—Vomiting—Valproic Acid—migraine	3.08e-05	0.000622	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Topiramate—migraine	3.07e-05	0.000622	CcSEcCtD
Atomoxetine—Insomnia—Topiramate—migraine	3.05e-05	0.000617	CcSEcCtD
Atomoxetine—Rash—Valproic Acid—migraine	3.05e-05	0.000617	CcSEcCtD
Atomoxetine—Dermatitis—Valproic Acid—migraine	3.05e-05	0.000617	CcSEcCtD
Atomoxetine—Pruritus—Timolol—migraine	3.05e-05	0.000616	CcSEcCtD
Atomoxetine—Headache—Valproic Acid—migraine	3.03e-05	0.000613	CcSEcCtD
Atomoxetine—Paraesthesia—Topiramate—migraine	3.03e-05	0.000613	CcSEcCtD
Atomoxetine—Somnolence—Topiramate—migraine	3e-05	0.000607	CcSEcCtD
Atomoxetine—Dyspepsia—Topiramate—migraine	2.97e-05	0.000601	CcSEcCtD
Atomoxetine—Diarrhoea—Timolol—migraine	2.95e-05	0.000596	CcSEcCtD
Atomoxetine—Decreased appetite—Topiramate—migraine	2.93e-05	0.000593	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Topiramate—migraine	2.91e-05	0.000589	CcSEcCtD
Atomoxetine—Fatigue—Topiramate—migraine	2.91e-05	0.000588	CcSEcCtD
Atomoxetine—Constipation—Topiramate—migraine	2.88e-05	0.000584	CcSEcCtD
Atomoxetine—Pain—Topiramate—migraine	2.88e-05	0.000584	CcSEcCtD
Atomoxetine—Asthenia—Gabapentin—migraine	2.88e-05	0.000582	CcSEcCtD
Atomoxetine—Nausea—Valproic Acid—migraine	2.87e-05	0.000581	CcSEcCtD
Atomoxetine—Dizziness—Timolol—migraine	2.85e-05	0.000576	CcSEcCtD
Atomoxetine—Pruritus—Gabapentin—migraine	2.84e-05	0.000574	CcSEcCtD
Atomoxetine—HTR2A—brain—migraine	2.81e-05	0.000924	CbGeAlD
Atomoxetine—Desipramine—SLC6A4—migraine	2.8e-05	0.0182	CrCbGaD
Atomoxetine—Feeling abnormal—Topiramate—migraine	2.78e-05	0.000562	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Topiramate—migraine	2.76e-05	0.000558	CcSEcCtD
Atomoxetine—Diarrhoea—Gabapentin—migraine	2.74e-05	0.000555	CcSEcCtD
Atomoxetine—Vomiting—Timolol—migraine	2.74e-05	0.000554	CcSEcCtD
Atomoxetine—Rash—Timolol—migraine	2.72e-05	0.000549	CcSEcCtD
Atomoxetine—Dermatitis—Timolol—migraine	2.71e-05	0.000549	CcSEcCtD
Atomoxetine—Headache—Timolol—migraine	2.7e-05	0.000546	CcSEcCtD
Atomoxetine—Urticaria—Topiramate—migraine	2.68e-05	0.000542	CcSEcCtD
Atomoxetine—Abdominal pain—Topiramate—migraine	2.67e-05	0.00054	CcSEcCtD
Atomoxetine—Body temperature increased—Topiramate—migraine	2.67e-05	0.00054	CcSEcCtD
Atomoxetine—Dizziness—Gabapentin—migraine	2.65e-05	0.000537	CcSEcCtD
Atomoxetine—Nortriptyline—HTR2A—migraine	2.62e-05	0.017	CrCbGaD
Atomoxetine—CYP2D6—brain—migraine	2.56e-05	0.000842	CbGeAlD
Atomoxetine—Nausea—Timolol—migraine	2.56e-05	0.000518	CcSEcCtD
Atomoxetine—Vomiting—Gabapentin—migraine	2.55e-05	0.000516	CcSEcCtD
Atomoxetine—Rash—Gabapentin—migraine	2.53e-05	0.000512	CcSEcCtD
Atomoxetine—Dermatitis—Gabapentin—migraine	2.53e-05	0.000511	CcSEcCtD
Atomoxetine—Headache—Gabapentin—migraine	2.51e-05	0.000508	CcSEcCtD
Atomoxetine—Asthenia—Topiramate—migraine	2.42e-05	0.00049	CcSEcCtD
Atomoxetine—Pruritus—Topiramate—migraine	2.39e-05	0.000483	CcSEcCtD
Atomoxetine—Nausea—Gabapentin—migraine	2.38e-05	0.000482	CcSEcCtD
Atomoxetine—Diarrhoea—Topiramate—migraine	2.31e-05	0.000467	CcSEcCtD
Atomoxetine—Dizziness—Topiramate—migraine	2.23e-05	0.000451	CcSEcCtD
Atomoxetine—Desipramine—HTR2A—migraine	2.15e-05	0.014	CrCbGaD
Atomoxetine—Vomiting—Topiramate—migraine	2.14e-05	0.000434	CcSEcCtD
Atomoxetine—Rash—Topiramate—migraine	2.13e-05	0.00043	CcSEcCtD
Atomoxetine—Dermatitis—Topiramate—migraine	2.13e-05	0.00043	CcSEcCtD
Atomoxetine—Headache—Topiramate—migraine	2.11e-05	0.000428	CcSEcCtD
Atomoxetine—Nausea—Topiramate—migraine	2e-05	0.000405	CcSEcCtD
Atomoxetine—HTR2C—G alpha (q) signalling events—HTR2A—migraine	1.75e-05	0.000472	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—HTR1D—migraine	1.73e-05	0.000467	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—HTR1B—migraine	1.73e-05	0.000466	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—CALCRL—migraine	1.73e-05	0.000465	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—RAMP1—migraine	1.73e-05	0.000465	CbGpPWpGaD
Atomoxetine—HTR6—GPCR ligand binding—HTR7—migraine	1.72e-05	0.000462	CbGpPWpGaD
Atomoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	1.7e-05	0.000458	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR ligand binding—HTR7—migraine	1.7e-05	0.000458	CbGpPWpGaD
Atomoxetine—HTR2A—GPCRs, Class A Rhodopsin-like—HTR7—migraine	1.68e-05	0.000452	CbGpPWpGaD
Atomoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	1.68e-05	0.000451	CbGpPWpGaD
Atomoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	1.68e-05	0.000451	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling by GPCR—HTR2A—migraine	1.67e-05	0.00045	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR ligand binding—HTR7—migraine	1.67e-05	0.000448	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—HTR1A—migraine	1.67e-05	0.000448	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—HTR2B—migraine	1.66e-05	0.000446	CbGpPWpGaD
Atomoxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	1.66e-05	0.000446	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—HTR2B—migraine	1.65e-05	0.000443	CbGpPWpGaD
Atomoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	1.65e-05	0.000443	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—NPS—migraine	1.64e-05	0.000442	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—TAC1—migraine	1.64e-05	0.000442	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—PGR—migraine	1.64e-05	0.000442	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—HTR2B—migraine	1.61e-05	0.000434	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—HTR2C—migraine	1.61e-05	0.000433	CbGpPWpGaD
Atomoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	1.6e-05	0.00043	CbGpPWpGaD
Atomoxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	1.58e-05	0.000425	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—RAMP1—migraine	1.57e-05	0.000423	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CALCRL—migraine	1.57e-05	0.000423	CbGpPWpGaD
Atomoxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	1.57e-05	0.000422	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—EDNRA—migraine	1.57e-05	0.000421	CbGpPWpGaD
Atomoxetine—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	1.57e-05	0.000421	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR ligand binding—HTR1B—migraine	1.55e-05	0.000417	CbGpPWpGaD
Atomoxetine—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	1.53e-05	0.000412	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—NOTCH3—migraine	1.53e-05	0.000411	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—CALCA—migraine	1.51e-05	0.000406	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR ligand binding—HTR1A—migraine	1.49e-05	0.000402	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR ligand binding—NPS—migraine	1.47e-05	0.000396	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR ligand binding—TAC1—migraine	1.47e-05	0.000396	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—RAMP1—migraine	1.45e-05	0.00039	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CALCRL—migraine	1.45e-05	0.00039	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—HTR1D—migraine	1.45e-05	0.000389	CbGpPWpGaD
Atomoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	1.44e-05	0.000388	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CALCRL—migraine	1.44e-05	0.000387	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—RAMP1—migraine	1.44e-05	0.000387	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CALCRL—migraine	1.41e-05	0.000379	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—RAMP1—migraine	1.41e-05	0.000379	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—HTR7—migraine	1.41e-05	0.000379	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR ligand binding—EDNRA—migraine	1.4e-05	0.000378	CbGpPWpGaD
Atomoxetine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	1.36e-05	0.000365	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR ligand binding—CALCA—migraine	1.35e-05	0.000363	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—HTR1B—migraine	1.35e-05	0.000362	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—HTR2B—migraine	1.35e-05	0.000362	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—HTR1D—migraine	1.31e-05	0.000354	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—HTR1A—migraine	1.3e-05	0.000349	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—NPS—migraine	1.28e-05	0.000344	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—TAC1—migraine	1.28e-05	0.000344	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR ligand binding—HTR7—migraine	1.26e-05	0.00034	CbGpPWpGaD
Atomoxetine—SLC6A4—SIDS Susceptibility Pathways—TNF—migraine	1.26e-05	0.000339	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—HTR1D—migraine	1.26e-05	0.000338	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—HTR2C—migraine	1.25e-05	0.000337	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—HTR2B—migraine	1.22e-05	0.000329	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—EDNRA—migraine	1.22e-05	0.000328	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—TGFBR2—migraine	1.21e-05	0.000327	CbGpPWpGaD
Atomoxetine—HTR6—GPCR ligand binding—HTR2A—migraine	1.2e-05	0.000323	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR ligand binding—HTR2A—migraine	1.19e-05	0.000321	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—HTR1B—migraine	1.19e-05	0.00032	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—HTR1B—migraine	1.18e-05	0.000318	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—CALCA—migraine	1.17e-05	0.000316	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—HTR2B—migraine	1.17e-05	0.000314	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR ligand binding—HTR2A—migraine	1.17e-05	0.000314	CbGpPWpGaD
Atomoxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	1.16e-05	0.000313	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—HTR1A—migraine	1.15e-05	0.000308	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—HTR1D—migraine	1.14e-05	0.000307	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—HTR1A—migraine	1.14e-05	0.000306	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—TAC1—migraine	1.13e-05	0.000304	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—NPS—migraine	1.13e-05	0.000304	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—TAC1—migraine	1.12e-05	0.000301	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—NPS—migraine	1.12e-05	0.000301	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—HTR1A—migraine	1.11e-05	0.0003	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—HTR2C—migraine	1.11e-05	0.000298	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—HTR2C—migraine	1.1e-05	0.000296	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—HTR7—migraine	1.1e-05	0.000295	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—NPS—migraine	1.1e-05	0.000295	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—TAC1—migraine	1.1e-05	0.000295	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—HTR1B—migraine	1.08e-05	0.000291	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—EDNRA—migraine	1.08e-05	0.00029	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—HTR2C—migraine	1.08e-05	0.000289	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—HTR1B—migraine	1.07e-05	0.000289	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—EDNRA—migraine	1.07e-05	0.000287	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—RAMP1—migraine	1.07e-05	0.000287	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CALCRL—migraine	1.07e-05	0.000287	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—HTR2B—migraine	1.06e-05	0.000285	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—HTR1D—migraine	1.05e-05	0.000284	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—EDNRA—migraine	1.05e-05	0.000282	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—HTR1A—migraine	1.04e-05	0.00028	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—CALCA—migraine	1.04e-05	0.000279	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—HTR1A—migraine	1.03e-05	0.000278	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—CALCA—migraine	1.03e-05	0.000277	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—TAC1—migraine	1.03e-05	0.000276	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—NPS—migraine	1.03e-05	0.000276	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—HTR1D—migraine	1.02e-05	0.000276	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—TAC1—migraine	1.02e-05	0.000274	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—NPS—migraine	1.02e-05	0.000274	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—HTR1A—migraine	1.01e-05	0.000272	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—CALCA—migraine	1.01e-05	0.000271	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—HTR2C—migraine	1.01e-05	0.00027	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—HTR2C—migraine	9.98e-06	0.000268	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—NPS—migraine	9.96e-06	0.000268	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—TAC1—migraine	9.96e-06	0.000268	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—HTR2A—migraine	9.88e-06	0.000266	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—HTR2B—migraine	9.8e-06	0.000264	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—EDNRA—migraine	9.78e-06	0.000263	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—HTR2C—migraine	9.77e-06	0.000263	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—HTR2B—migraine	9.73e-06	0.000262	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—EDNRA—migraine	9.71e-06	0.000261	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—HTR7—migraine	9.7e-06	0.000261	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—HTR7—migraine	9.62e-06	0.000259	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—HTR2B—migraine	9.52e-06	0.000256	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—EDNRA—migraine	9.5e-06	0.000256	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—HTR7—migraine	9.42e-06	0.000253	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—CALCA—migraine	9.41e-06	0.000253	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—CALCA—migraine	9.34e-06	0.000251	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CALCRL—migraine	9.28e-06	0.00025	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—RAMP1—migraine	9.28e-06	0.00025	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—CALCA—migraine	9.15e-06	0.000246	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR ligand binding—HTR2A—migraine	8.85e-06	0.000238	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—HTR7—migraine	8.81e-06	0.000237	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—HTR1B—migraine	8.77e-06	0.000236	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—ESR1—migraine	8.77e-06	0.000236	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—HTR7—migraine	8.74e-06	0.000235	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—LRP1—migraine	8.63e-06	0.000232	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—LRP1—migraine	8.56e-06	0.00023	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—HTR7—migraine	8.56e-06	0.00023	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—HTR1A—migraine	8.44e-06	0.000227	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—LRP1—migraine	8.39e-06	0.000226	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—NPS—migraine	8.31e-06	0.000224	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—TAC1—migraine	8.31e-06	0.000224	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—HTR1B—migraine	7.96e-06	0.000214	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—EDNRA—migraine	7.93e-06	0.000213	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—HTR1D—migraine	7.76e-06	0.000209	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—HTR1A—migraine	7.67e-06	0.000206	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—CALCA—migraine	7.63e-06	0.000205	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—HTR1B—migraine	7.62e-06	0.000205	CbGpPWpGaD
Atomoxetine—HTR2A—SIDS Susceptibility Pathways—TNF—migraine	7.58e-06	0.000204	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—TAC1—migraine	7.55e-06	0.000203	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—NPS—migraine	7.55e-06	0.000203	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—HTR1A—migraine	7.33e-06	0.000197	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—NPS—migraine	7.22e-06	0.000194	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—TAC1—migraine	7.22e-06	0.000194	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—HTR2B—migraine	7.22e-06	0.000194	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—EDNRA—migraine	7.2e-06	0.000194	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—HTR7—migraine	7.14e-06	0.000192	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—HTR2C—migraine	7.08e-06	0.00019	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—CALCA—migraine	6.93e-06	0.000186	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—HTR1B—migraine	6.92e-06	0.000186	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—EDNRA—migraine	6.89e-06	0.000185	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—HTR2A—migraine	6.79e-06	0.000183	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—HTR1D—migraine	6.74e-06	0.000181	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—HTR2A—migraine	6.74e-06	0.000181	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—HTR1A—migraine	6.66e-06	0.000179	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—CALCA—migraine	6.63e-06	0.000178	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—NOTCH4—migraine	6.62e-06	0.000178	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—HTR2A—migraine	6.6e-06	0.000178	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—NOTCH4—migraine	6.57e-06	0.000177	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—TAC1—migraine	6.56e-06	0.000176	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—NPS—migraine	6.56e-06	0.000176	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—HTR7—migraine	6.48e-06	0.000174	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—NOTCH4—migraine	6.43e-06	0.000173	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—HTR2C—migraine	6.43e-06	0.000173	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—HTR1B—migraine	6.39e-06	0.000172	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—LRP1—migraine	6.36e-06	0.000171	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—HTR1B—migraine	6.34e-06	0.000171	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—HTR2B—migraine	6.27e-06	0.000169	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—EDNRA—migraine	6.25e-06	0.000168	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—HTR7—migraine	6.2e-06	0.000167	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—HTR2A—migraine	6.17e-06	0.000166	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—HTR1A—migraine	6.15e-06	0.000165	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—HTR2A—migraine	6.12e-06	0.000165	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—HTR1A—migraine	6.1e-06	0.000164	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—PGR—migraine	6.06e-06	0.000163	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—TAC1—migraine	6.06e-06	0.000163	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—NPS—migraine	6.06e-06	0.000163	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CALCA—migraine	6.02e-06	0.000162	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—PGR—migraine	6.01e-06	0.000162	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—NPS—migraine	6.01e-06	0.000162	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—TAC1—migraine	6.01e-06	0.000162	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—HTR2A—migraine	5.99e-06	0.000161	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—HTR1A—migraine	5.98e-06	0.000161	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—HTR2C—migraine	5.94e-06	0.00016	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—HTR2C—migraine	5.89e-06	0.000159	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—NPS—migraine	5.88e-06	0.000158	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—TAC1—migraine	5.88e-06	0.000158	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—PGR—migraine	5.88e-06	0.000158	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—EDNRA—migraine	5.78e-06	0.000155	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—HTR2C—migraine	5.77e-06	0.000155	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—EDNRA—migraine	5.73e-06	0.000154	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—HTR7—migraine	5.63e-06	0.000151	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—NOTCH3—migraine	5.63e-06	0.000151	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—EDNRA—migraine	5.61e-06	0.000151	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—NOTCH3—migraine	5.59e-06	0.00015	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CALCA—migraine	5.56e-06	0.00015	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—LRP1—migraine	5.52e-06	0.000148	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CALCA—migraine	5.52e-06	0.000148	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—NOTCH3—migraine	5.47e-06	0.000147	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—CACNA1A—migraine	5.42e-06	0.000146	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CALCA—migraine	5.4e-06	0.000145	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—HTR7—migraine	5.2e-06	0.00014	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—HTR7—migraine	5.16e-06	0.000139	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—HTR7—migraine	5.05e-06	0.000136	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—HTR2A—migraine	5e-06	0.000135	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—CACNA1A—migraine	4.99e-06	0.000134	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—NOTCH4—migraine	4.88e-06	0.000131	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—HTR1B—migraine	4.7e-06	0.000127	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—HTR2A—migraine	4.54e-06	0.000122	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—HTR1A—migraine	4.53e-06	0.000122	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—TGFBR2—migraine	4.48e-06	0.00012	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—NPS—migraine	4.46e-06	0.00012	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—TAC1—migraine	4.46e-06	0.00012	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—PGR—migraine	4.46e-06	0.00012	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—TGFBR2—migraine	4.45e-06	0.00012	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—TGFBR2—migraine	4.35e-06	0.000117	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—EDNRA—migraine	4.25e-06	0.000114	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—NOTCH4—migraine	4.23e-06	0.000114	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—NOTCH3—migraine	4.15e-06	0.000112	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CALCA—migraine	4.1e-06	0.00011	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—HTR1B—migraine	4.09e-06	0.00011	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—HTR1A—migraine	3.93e-06	0.000106	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—PGR—migraine	3.87e-06	0.000104	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—NPS—migraine	3.87e-06	0.000104	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—TAC1—migraine	3.87e-06	0.000104	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—HTR7—migraine	3.83e-06	0.000103	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—HTR2C—migraine	3.8e-06	0.000102	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—EDNRA—migraine	3.69e-06	9.94e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—HTR2A—migraine	3.64e-06	9.8e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—HTR2A—migraine	3.62e-06	9.73e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—NOTCH3—migraine	3.6e-06	9.68e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CALCA—migraine	3.56e-06	9.57e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—HTR2A—migraine	3.54e-06	9.52e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—HTR7—migraine	3.33e-06	8.95e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—TGFBR2—migraine	3.3e-06	8.87e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—CACNA1A—migraine	3.26e-06	8.77e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—ESR1—migraine	3.23e-06	8.7e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—ESR1—migraine	3.21e-06	8.63e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—ESR1—migraine	3.14e-06	8.45e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—TGFBR2—migraine	2.86e-06	7.71e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—HTR2A—migraine	2.68e-06	7.22e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—ESR1—migraine	2.38e-06	6.41e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—ESR1—migraine	2.07e-06	5.56e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—MTHFR—migraine	1.79e-06	4.82e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—MTHFR—migraine	1.65e-06	4.44e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—MTHFR—migraine	1.08e-06	2.9e-05	CbGpPWpGaD
